The UK has another new Prime Minister, Andy Burnham, who has wasted no time in laying out his plans to fundamentally reform the country’s creaking healthcare infrastructure.
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and sustained growth over the last seven years.
Ahead of the Cannabis Europa 2026, which kicks off next Tuesday (June 24) at the Barbican Centre, we caught up with Eidan Havas, the Founder of one of Australia’s leading medical cannabis product wholesalers, The Entourage Effect.
Creating a culture that focuses on the behaviours required to achieve the results desired, has been the root cause of Releaf’s success in the UK’s medical cannabis sector – a sector that has stagnated since medical cannabis became legal in 2018.
BRITISH CANNABIS™, a staple of the UK’s cannabis industry, has now cemented its position in the medical cannabis space with a range of strain-specific sublingual cannabis oils.
Rui Soares is the founder and CEO of Paralab Green, a leading company specialising in advanced technology for cannabis postharvest and cannabinoid extraction.
The medical cannabis sector in the UK is navigating a dual imperative: ensuring rigorous compliance with regulatory standards while delivering compassionate care to patients in need. For UK medical cannabis clinic Releaf, these two objectives are not only complementary but also foundational to its operations.
With the demand for cannabis-derived products skyrocketing globally, Yogesh walks us through how Buffalo Extraction Systems has positioned itself as more than just an equipment provider and how they act as a dedicated technology partner to their clients.
Over half of the UK’s population could benefit from medical cannabis, but the lack of awareness means millions of potential patients continue to turn to other treatments.
